Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab

2018 
2521Background: Most targeted treatments are associated with biomarkers, predictive of drug response. Although bevacizumab is widely used, there are still no available biomarkers. Given the need of...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []